Billion Dollar Antibiotics in the Era of Stewardship:

It is Possible by Following 3 Guiding Principles

Billion Dollar Antibiotics in the Era of Stewardship:

By: Cristina Larkin, David Melnick, M.D., and Keith A. Rodvold, Pharm.D., FCCP, FIDSA April 25th, 2018 Can billion-dollar antibiotics and stewardship co-exist?  In an era where we are seeing increasing resistance to antibiotics it seems intuitive that there would be large market opportunity for new, effective antibiotics.  However, peak year sales of recent launches haven’t lived up to […]